Non-Hodgkin's lymphomas, version 1.2013: Featured updates to the NCCN guidelines

Andrew D. Zelenetz, William G. Wierda, Jeremy S. Abramson, Ranjana H. Advani, C. Babis Andreadis, Nancy Bartlett, Naresh Bellam, John C. Byrd, Myron S. Czuczman, Luis E. Fayad, Martha J. Glenn, Jon P. Gockerman, Leo I. Gordon, Nancy Lee Harris, Richard T. Hoppe, Steven M. Horwitz, R. Kelsey Christopher, Youn H. Kim, Susan Krivacic, Ann S. LaCasceAuayporn Nademanee, Pierluigi Porcu, Oliver Press, Barbara Pro, Nishitha Reddy, Lubomir Sokol, Lode Swinnen, Christina Tsien, Julie M. Vose, Joachim Yahalom, Nadeem Zafar, Mary A. Dwyer, Maoko Naganuma

Research output: Contribution to journalReview article

43 Scopus citations

Abstract

These NCCN Guidelines Insights summarize several key updates to the NCCN Guidelines for Non-Hodgkin's Lymphomas (NHL) and provide a discussion of the clinical evidence that support the updates. The updates discussed in this article feature recommendations for additional treatment options in patients with chronic lymphocytic leukemia and guidance surrounding the management of hepatitis virus reactivation/infections in high-risk patients with NHL undergoing antitumor therapy.

Original languageEnglish (US)
Pages (from-to)257-273
Number of pages17
JournalJNCCN Journal of the National Comprehensive Cancer Network
Volume11
Issue number3
DOIs
StatePublished - Mar 1 2013

ASJC Scopus subject areas

  • Oncology

Fingerprint Dive into the research topics of 'Non-Hodgkin's lymphomas, version 1.2013: Featured updates to the NCCN guidelines'. Together they form a unique fingerprint.

  • Cite this

    Zelenetz, A. D., Wierda, W. G., Abramson, J. S., Advani, R. H., Andreadis, C. B., Bartlett, N., Bellam, N., Byrd, J. C., Czuczman, M. S., Fayad, L. E., Glenn, M. J., Gockerman, J. P., Gordon, L. I., Harris, N. L., Hoppe, R. T., Horwitz, S. M., Christopher, R. K., Kim, Y. H., Krivacic, S., ... Naganuma, M. (2013). Non-Hodgkin's lymphomas, version 1.2013: Featured updates to the NCCN guidelines. JNCCN Journal of the National Comprehensive Cancer Network, 11(3), 257-273. https://doi.org/10.6004/jnccn.2013.0037